Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Mallinckrodt Life Science Investing
MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 for Amyotrophic Lateral Sclerosis Biotech Investing
Peregrine Pharmaceuticals Reports Top-Line and Initial Biomarker Data from Phase III SUNRISE Trial of Bavituximab Biotech Investing
Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA® In Advanced Renal Cell Carcinoma Biotech Investing
